Wang, Y.; Shao, A.; Wang, W.; Huang, Q.; Yan, W.; Lan, M. Middle Meningeal Artery Embolization Reduces the Recurrence Rate of Chronic Subdural Hematoma. Preprints2023, 2023110925. https://doi.org/10.20944/preprints202311.0925.v1
APA Style
Wang, Y., Shao, A., Wang, W., Huang, Q., Yan, W., & Lan, M. (2023). Middle Meningeal Artery Embolization Reduces the Recurrence Rate of Chronic Subdural Hematoma. Preprints. https://doi.org/10.20944/preprints202311.0925.v1
Chicago/Turabian Style
Wang, Y., Wei Yan and Meijuan Lan. 2023 "Middle Meningeal Artery Embolization Reduces the Recurrence Rate of Chronic Subdural Hematoma" Preprints. https://doi.org/10.20944/preprints202311.0925.v1
Abstract
To evaluate the effect of middle meningeal artery embolization (MMAE) on chronic subdural hematoma (CSDH). We enrolled consecutive patients with CSDH who underwent burr hole craniostomy (BHC) between January 2021 and February 2023. The primary outcome was recurrence rate, defined as an increase of hematoma width on imaging compared with the immediate postoperative imaging at a 3-month follow-up. Secondary outcomes included the rate of complications and adverse prognosis. Cohorts were balanced using 1:2 propensity score matching (PSM). A total of 271 patients were eligible for this study and divided into the MMAE group (n=23) and the BHC group (n=205). Compared with the BHC group, there was more use of anticoagulant or antiplatelet medication (47.8% vs 22.4%, P=0.008), bilateral hematoma (19.5% vs 19.5%, P=0.043) and hematoma with septations (47.8% vs 21.5%, P=0.005) in the MMAE group. After PSM, 64 cases were finally successfully matched. The logistic analysis result showed that MMAE was associated with the decreased recurrence rate of CSDH in the cohort after PSM (OR 0.072, 95%CI 0.322~0.746, P=0.028) but not with the improved clinical prognosis (OR 0.065, 95%CI 0.533~4.786, P=0.562). MAAE has a positive therapeutic effect on reducing the recurrence rate of CSDHs as an adjunct postoperative treatment after burr hole surgery.
Biology and Life Sciences, Neuroscience and Neurology
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
